Analytical Services Center for Medications Development Program
This federal contract opportunity has been awarded to on July 17, 2026.
Award Information
This solicitation resulted in an award to for approximately $5,000,000 on July 17, 2026. Similar contracts are typically issued by HEALTH AND HUMAN SERVICES, DEPARTMENT OF under 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
- Award Number
- 75N98026D00031
- Award Amount
- $5,000,000
- Award Date
- July 17, 2026
Key Takeaways
- No response deadline specified - contact the agency for details
- Full and open competition - all businesses eligible to bid
- Work to be performed in Bethesda, MD
- Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Contract Details
- Notice ID
- 75N98026D00031
- Opportunity Type
- Award Notice
- Sub-Agency
- NATIONAL INSTITUTES OF HEALTH
- Office
- NATIONAL INSTITUTES OF HEALTH NIDA
- Posted Date
- Friday, July 17, 2026
- Response Deadline
- Not specified
- PSC Code
- AN11
- Set-Aside
- Full & Open Competition
- Place of Performance
- Bethesda, MD, 20892
- Status
- Active
Description
NOTICE OF AWARD. THIS IS NOT A REQUEST FOR QUOTE/PROPOSALS. On July 17, 2022; in response to the requirements of Solicitation 75N95024R00032, the National Institute on Drug Abuse (NIDA) awarded Contract No. 75N98026D00031 to MRIGlobal for the Analytical Services Center for Medications Development . NIDA anticipates the use of Task Orders with an ultimate Period of Performance of five (5) years. An award shall be made on a Cost Plus Fixed Fee and Firm Fixed Price basis.
Why This Opportunity Matters
HEALTH AND HUMAN SERVICES, DEPARTMENT OF is seeking responses for research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) in Bethesda, MD.
Similar Opportunities
Browse Related
Looking for more opportunities?
Browse our full directory of government contracts
